Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen C Bain

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 24, 2009
Treatment of type 2 diabetes mellitus with orally administered agents: advances in combination therapyStephen C Bain
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 17, 2014
The clinical development program of lixisenatide: a once-daily glucagon-like Peptide-1 receptor agonistStephen C Bain
Endocrinology and Metabolism (Seoul, Korea)|February 6, 2023
Glucagon-Like Peptide 1 Therapy: From Discovery to Type 2 Diabetes and BeyondAdie Viljoen, Stephen C Bain
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 16, 2020
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical TrialsThinzar Min, Stephen C Bain
Expert Opinion on Emerging Drugs|March 10, 2023
Emerging drugs for the treatment of type 1 diabetes mellitus: a review of phase 2 clinical trialsThinzar Min, Stephen C Bain
Drug Design, Development and Therapy|September 17, 2013
A review of sitagliptin with special emphasis on its use in moderate to severe renal impairmentVinay S Eligar, Stephen C Bain
Expert Opinion on Drug Safety|August 11, 2007
Safety and adverse effects associated with GLP-1 analoguesJeffrey W Stephens, Stephen C Bain
Expert Opinion on Drug Safety|December 22, 2006
Insulin glulisine: efficacy and safety compared with other rapid-acting insulin analoguesAli D Kamal, Stephen C Bain
Expert Review of Clinical Pharmacology|June 2, 2020
Semaglutide injection for the treatment of adults with type 2 diabetesRichard A Chudleigh, Stephen C Bain
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 19, 2024
The Regulation of Metabolic Homeostasis by Incretins and the Metabolic Hormones Produced by Pancreatic IsletsJoshua Reed, Stephen C Bain, Venkateswarlu Kanamarlapudi
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 24, 2009
Treatment of type 2 diabetes mellitus with orally administered agents: advances in combination therapyStephen C Bain
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 17, 2014
The clinical development program of lixisenatide: a once-daily glucagon-like Peptide-1 receptor agonistStephen C Bain
Endocrinology and Metabolism (Seoul, Korea)|February 6, 2023
Glucagon-Like Peptide 1 Therapy: From Discovery to Type 2 Diabetes and BeyondAdie Viljoen, Stephen C Bain
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 16, 2020
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical TrialsThinzar Min, Stephen C Bain
Expert Opinion on Emerging Drugs|March 10, 2023
Emerging drugs for the treatment of type 1 diabetes mellitus: a review of phase 2 clinical trialsThinzar Min, Stephen C Bain
Drug Design, Development and Therapy|September 17, 2013
A review of sitagliptin with special emphasis on its use in moderate to severe renal impairmentVinay S Eligar, Stephen C Bain
Expert Opinion on Drug Safety|August 11, 2007
Safety and adverse effects associated with GLP-1 analoguesJeffrey W Stephens, Stephen C Bain
Expert Opinion on Drug Safety|December 22, 2006
Insulin glulisine: efficacy and safety compared with other rapid-acting insulin analoguesAli D Kamal, Stephen C Bain
Expert Review of Clinical Pharmacology|June 2, 2020
Semaglutide injection for the treatment of adults with type 2 diabetesRichard A Chudleigh, Stephen C Bain
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 19, 2024
The Regulation of Metabolic Homeostasis by Incretins and the Metabolic Hormones Produced by Pancreatic IsletsJoshua Reed, Stephen C Bain, Venkateswarlu Kanamarlapudi
Pageof 13